Kobayashi Y, Kikushima S, Tanno K, Kurano K, Baba T, Katagiri T
Third Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan.
Pacing Clin Electrophysiol. 1994 Mar;17(3 Pt 1):377-85. doi: 10.1111/j.1540-8159.1994.tb01401.x.
Sustained VT in two patients was terminated by intravenous administration of dipyridamole, an adenosine transport inhibitor. VT was induced by rapid atrial or ventricular pacing, isoproterenol, or dibutyryl cyclic AMP infusion, or exercise. VT also was aborted by adenosine triphosphate or acetylcholine injection, or by vagal stimulation. VT was terminated or prevented by verapamil or propranolol. In addition, arrhythmias were prevented by oral administration of dipyridamole. These results suggest that VT is due to cyclic AMP-mediated triggered activity and that inhibition by dipyridamole may be due to a reduction in the intracellular concentration of cyclic AMP.
两名患者的持续性室性心动过速通过静脉注射双嘧达莫(一种腺苷转运抑制剂)得以终止。室性心动过速由快速心房或心室起搏、异丙肾上腺素、二丁酰环磷腺苷输注或运动诱发。三磷酸腺苷或乙酰胆碱注射,或迷走神经刺激也能中止室性心动过速。维拉帕米或普萘洛尔可终止或预防室性心动过速。此外,口服双嘧达莫可预防心律失常。这些结果表明,室性心动过速是由环磷腺苷介导的触发活动所致,双嘧达莫的抑制作用可能是由于细胞内环磷腺苷浓度降低。